Authors/Disclosures
|
|
No disclosure on file |
|
Amy B. Sullivan, PhD
(Cleveland Clinic)
|
Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Serono. Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. |
|
Afnan Alhakeem, MD
(Prince Sultan Medical City)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Daniel Ontaneda, MD, PhD, FAAN
(Cleveland Clinic)
|
Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech. |
|
Carrie M. Hersh, DO, MSc, FAAN
(Cleveland Clinic Lou Ruvo Center for Brain Health)
|
Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb. |
|
Henrik Zetterberg
(Sahlgrenska University Hospital/Molndal)
|
No disclosure on file |